| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000031130 |
| Receipt No. | R000035559 |
| Official scientific title of the study | Observational study on biomarker search of gastrointestinal tumors by flow cytometry |
| Date of disclosure of the study information | 2018/02/20 |
| Last modified on | 2018/02/04 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Observational study on biomarker search of gastrointestinal tumors by flow cytometry | |
| Title of the study (Brief title) | Observational study on biomarker search of gastrointestinal tumors by flow cytometry | |
| Region |
|
|
| Condition | ||||
| Condition | Esophageal cancer, Gastric cancer, Colorectal cancer | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | YES | |||
| Objectives | |
| Narrative objectives1 | Quantitatively evaluate the cell cycle status of the tumor tissue cells using a rapid flow cytometric machine called Celltac PEAK and compare it with the clinicopathological factor, therapeutic effect, prognosis and establish a new biomarker As the aim of this research. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Overall survival |
| Key secondary outcomes | relapse free / progression-free survival period, pathology result, tumor marker etc., treatment effect (RECIST), numerical value measurable by image (tumor size, contrast effect, FDG-PET sugar metabolic rate, ADC value etc. ), Tumor genetic mutation (colon cancer) |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients aged 20 years or older who received a sufficient explanation about this research and received understanding and document consent by free will. | |||
| Key exclusion criteria | In the case of insufficient tissue volume for this examination during endoscopic examination or surgery. When consent on this research can not be obtained. |
|||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Hisahiro Matsubara |
| Organization | Graduate school of medicine, Chiba University |
| Division name | Department of frontier surgery |
| Address | 1-8-1, Inohana, Chuo Ward, Chiba-shi, Chiba |
| TEL | 043-226-2109 |
| matsuhm@faculty.chiba-u.jp | |
| Public contact | |
| Name of contact person | Hiroyuki Amagai |
| Organization | Graduate school of medicine, Chiba University |
| Division name | Department of frontier surgery |
| Address | 1-8-1, Inohana, Chuo Ward, Chiba-shi, Chiba |
| TEL | 043-226-2109 |
| Homepage URL | |
| afua2633@chiba-u.jp | |
| Sponsor | |
| Institute | Graduate school of medicine, Chiba University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | NIHON KOHDEN CORPORATION |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Analyze the DNA histogram of tissues using Celltac PEAK and quantitatively evaluate the cell cycle state of tumor cells in the tissue. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035559 |